| NASDAQ (usa) |
 |
6715.56 | -12.11 | -0.18% |
| FTSE 100 (london) |
|
7487.96 | -5.12 | -0.07% |
| DAX (german) |
 |
13465.51 | 235.94 | 1.78% |
| NIKKEI 225 (japan) |
|
22420.08 | 408.47 | 1.86% |
| Hang - Seng (hong kong) |
|
28594.06 | 348.52 | 1.23% |
| NIFTY - 50 (india) | ||||
| Straits Times (singapore) |
|
3391.61 | 17.53 | 0.52% |
| KOSPI (korea) |
|
2556.47 | 33.04 | 1.31% |
| All Ordinaries (australia) |
|
6005.30 | 28.90 | 0.48% |
| BOVESPA (brazil) |
|
74092.76 | -215.73 | -0.29% |
Gracell Biotechnologies Inc (NASDAQ: GRCL)
GRCL Technical Analysis
1.5
| As on 9th Jun 2023 GRCL STOCK Price closed @ 4.00 and we RECOMMEND Buy for LONG-TERM with Stoploss of 3.40 & Sell for SHORT-TERM with Stoploss of 4.19 we also expect STOCK to react on Following IMPORTANT LEVELS. |
GRCLSTOCK Price
| Open | 3.76 | Change | Price | % |
| High | 4.08 | 1 Day | 0.07 | 1.78 |
| Low | 3.70 | 1 Week | 1.26 | 45.99 |
| Close | 4.00 | 1 Month | 2.47 | 161.44 |
| Volume | 366645 | 1 Year | -2.46 | -38.08 |
| 52 Week High 6.56 | 52 Week Low 1.45 | ||||
NASDAQ USA Most Active Stocks
| TSLA | 244.40 | 4.06% |
| TTOO | 0.07 | -12.50% |
| SOFI | 8.18 | 0.74% |
| FFIE | 0.33 | 6.45% |
| PONO | 1.72 | 2.38% |
| AMD | 124.92 | 3.20% |
| IDEX | 0.06 | 0.00% |
| NKLA | 0.70 | 14.75% |
| AMZN | 123.43 | -0.66% |
| AAPL | 180.96 | 0.22% |
NASDAQ USA Top Gainers Stocks
NASDAQ USA Top Losers Stocks
| GRCL Daily Charts |
GRCL Intraday Charts |
Whats New @ Bazaartrend |
GRCL Free Analysis |
|
|
GRCL Important Levels Intraday
| RESISTANCE | 4.73 |
| RESISTANCE | 4.50 |
| RESISTANCE | 4.35 |
| RESISTANCE | 4.21 |
| SUPPORT | 3.79 |
| SUPPORT | 3.65 |
| SUPPORT | 3.50 |
| SUPPORT | 3.27 |
GRCL Forecast May 2024
| 4th UP Forecast | 8.93 |
| 3rd UP Forecast | 7.35 |
| 2nd UP Forecast | 6.37 |
| 1st UP Forecast | 5.4 |
| 1st DOWN Forecast | 2.6 |
| 2nd DOWN Forecast | 1.63 |
| 3rd DOWN Forecast | 0.65 |
| 4th DOWN Forecast | -0.93 |
GRCL Weekly Forecast
| 4th UP Forecast | 6.95 |
| 3rd UP Forecast | 6.00 |
| 2nd UP Forecast | 5.42 |
| 1st UP Forecast | 4.83 |
| 1st DOWN Forecast | 3.17 |
| 2nd DOWN Forecast | 2.58 |
| 3rd DOWN Forecast | 2.00 |
| 4th DOWN Forecast | 1.05 |
GRCL Forecast2024
| 4th UP Forecast | 14.02 |
| 3rd UP Forecast | 10.81 |
| 2nd UP Forecast | 8.82 |
| 1st UP Forecast | 6.83 |
| 1st DOWN Forecast | 1.17 |
| 2nd DOWN Forecast | -0.82 |
| 3rd DOWN Forecast | -2.81 |
| 4th DOWN Forecast | -6.02 |
Gracell Biotechnologies Inc ( NASDAQ USA Symbol : GRCL )
Sector : Healthcare And Other Stocks in Same Sector
Sector : Healthcare And Other Stocks in Same Sector
GRCL Business Profile
Gracell Biotechnologies Inc., a clinical-stage biopharmaceutical company, primarily discovers and develops cell therapies for the treatment of cancer in the People's Republic of China. Its lead product candidates include GC012F, a FasTCAR-enabled dual BCMA- and CD19-directed autologous CAR-T product candidate that is in Phase I trial for the treatment of multiple myeloma; GC019F, a FasTCAR-enabled CD19-directed autologous CAR-T product candidate, which is in Phase I clinical trial for the treatment of adult B cell acute lymphoblastic leukemia (B-ALL), as well as in preclinical stage for the treatment of relapsed or refractory (r/r) B cell non-Hodgkin's lymphoma (B-NHL); and GC027, a TruUCAR-enabled CD7-directed allogeneic CAR-T product candidate, which is in Phase I clinical trial for the treatment of adult T cell acute lymphoblastic leukemia. The company's product candidates also comprise; and GC007g, a donor-derived CD19-directed allogeneic CAR-T cell therapy that is in Phase I clinical trial for the treatment of r/r B-ALL. In addition, it has a portfolio of earlier stage product candidates targeting various cancer indications, such as ovarian cancer, breast cancer, peripheral T cell lymphoma, a subtype of NHL, and T cell lymphoblastic leukemia. The company was founded in 2017 and is headquartered in Suzhou, China. Address: Building 12, Block B, Suzhou, China, 215123
© 2005-2023 BazaarTrend.com All rights reserved.
Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service
Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service